Amedisys Inc
(STU:ADY)
€
87
0 (0%)
Market Cap: 2.90 Bil
Enterprise Value: 3.24 Bil
PE Ratio: 0
PB Ratio: 2.87
GF Score: 85/100 Amedisys Inc at Raymond James Institutional Investors Conference (Virtual) Transcript
Mar 03, 2021 / 02:10PM GMT
Release Date Price:
€200
(-6.54%)
John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research
All right. Good morning, everyone. Welcome to the last Virtual Day of the Raymond James Institutional Investor Conference. Here for a repeat performance, we're delighted to have the team from Amedisys, and I would note, we've got a full team on the field. We've got Nick and Paul and Scott and Chris. And the company is just coming off of a fourth quarter earnings report and a guide. So there's lots to get to.
So what I would -- and this is a fireside chat. If you have questions, you can e-mail me at [email protected], where you can hit the question dialogue, I believe, in the upper left of the box.
Questions & Answers
John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research
So without any further preamble. Just wanted to kind of set -- let's take a step back in the way back machine. And Wall Street, and I was
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot